← All Immunovant, INC filings

Immunovant, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
IMVT
Immunovant, INC
SCHEDULE: Deep Track Capital Discloses 4.55% Stake in Immunovant
Investment firm Deep Track Capital, along with its affiliates, has reported beneficial ownership of 9,341,151 shares, representing 4.55% of Immunovant, Inc.'s common stock.
NASDAQ
IMVT
Immunovant, INC
SCHEDULE: FMR LLC & Abigail Johnson Boost Immunovant Stake to 8.4%
FMR LLC and its affiliates, along with Abigail P. Johnson, have reported a beneficial ownership of 8.4% of Immunovant Inc.'s common stock as of September 30, 2025.
NASDAQ
IMVT
Immunovant, INC
SCHEDULE 13G: Deep Track Capital Discloses 5.59% Stake in Immunovant Inc.
Deep Track Capital, along with its affiliates, has disclosed a beneficial ownership of 5.59% in Immunovant Inc., totaling 9.5 million shares of common stock.
NASDAQ
IMVT
Immunovant, INC
SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Maintain Significant 10.1% Stake in Immunovant Inc.
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a continued beneficial ownership of 10.1% of Immunovant Inc.'s common stock as of February 28, 2025.